These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19691583)

  • 21. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
    Steppich BA; Seitz I; Busch G; Stein A; Ott I
    Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor.
    Ndonwi M; Broze G
    J Thromb Haemost; 2008 Jun; 6(6):1044-6. PubMed ID: 18419747
    [No Abstract]   [Full Text] [Related]  

  • 23. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
    Rapaport SI
    Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
    [No Abstract]   [Full Text] [Related]  

  • 24. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
    Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
    Migdalski A; Kotschy M; Jawien A
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood coagulation and fibrinolysis: an overview.
    Mosher DF
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI5-11. PubMed ID: 2191814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparanase coagulation and cancer progression.
    Nadir Y; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet tissue factor pathway inhibitor modulates intravascular coagulation.
    Maroney SA; Mast AE
    Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S21-2. PubMed ID: 22425319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
    Lupu C; Kruithof EK; Kakkar VV; Lupu F
    Thromb Haemost; 1999 Dec; 82(6):1652-8. PubMed ID: 10613651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The present status of tissue factor pathway inhibitor.
    Lindahl AK; Sandset PM; Abildgaard U
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):439-49. PubMed ID: 1420819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
    Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells.
    Zhao Y; Zhou S; Heng CK
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1645-50. PubMed ID: 17463335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparanase procoagulant effects and inhibition by heparins.
    Nadir Y; Brenner B
    Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Pilot Study of Tissue Factor-Tissue Factor Pathway Inhibitor Axis and Other Selected Coagulation Parameters in Broiler Chickens Administered in Ovo with Selected Prebiotics*.
    Buzala M; Ponczek MB; Slomka A; Roslewska A; Janicki B; Zekanowska E; Bednarczyk M
    Folia Biol (Krakow); 2016; 64(4):213-224. PubMed ID: 29809360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.